Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

NCT00221312 · clinicaltrials.gov ↗

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Perimenopausal Bone Loss

Interventions

DRUG: Fosamax

Sponsor

University of California, San Francisco